Viewing Study NCT03356912


Ignite Creation Date: 2025-12-26 @ 11:09 AM
Ignite Modification Date: 2025-12-26 @ 11:09 AM
Study NCT ID: NCT03356912
Status: UNKNOWN
Last Update Posted: 2017-12-14
First Post: 2017-10-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy
Sponsor: Consorzio Oncotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module